Investment Banking
Co-Lead Manager on Praxis Precision Medicines’ $661.4MM CMPO
January 12, 2026
Oppenheimer & Co. Inc. acted as Co-Lead Manager on Praxis Precision Medicines’ $661.4MM Confidentially Marketed Public Offering
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, announced the pricing of its underwritten public offering of 2,543,800 shares of its common stock at a public offering price per share of $260.00. The gross proceeds from the offering are expected to be approximately $661 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Praxis. All shares in the offering are being offered by Praxis. The underwriters exercised a 30-day option to purchase up to 331,800 additional shares of common stock at the public offering price, less underwriting discounts and commissions.
Healthcare Life Sciences Investment Banking
Name:
Michael A. Margolis, R.Ph.
Title:Senior Managing Director, Head of Healthcare Life Sciences Investment Banking
DISCLOSURES
This notice is provided for informational purposes only and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.
This notice may contain statistical data cited from third-party sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.
Oppenheimer & Co. Inc. Transacts Business on all Principal US Exchanges and is a Member of SIPC 8704007.1